Bluejay Diagnostics (BJDX) Other Non-Current Assets (2021 - 2026)
Bluejay Diagnostics (BJDX) reported Other Non-Current Assets of $10832.0 for Q1 2026, down 68.54% on a YoY basis from $34435.0 in Q1 2025, and up 37.03% sequentially from $7905.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 6 years of Other Non-Current Assets data on file, last reported at $10832.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 68.54% year-over-year to $10832.0; the trailing twelve-month figure through Mar 2026 stood at $10832.0 (down 68.54% YoY), and the FY2025 full-year result was $7905.0, down 77.58% from the prior year.
- Other Non-Current Assets advanced to $10832.0 in Q1 2026, from $7905.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $35257.0 in Q4 2024 to a low of $7905.0 in Q4 2025.
- A 5-year average of $25895.5 and a median of $28663.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets jumped 67.52% in 2022 and sank 77.58% in 2025, its largest moves.
- Tracing BJDX's Other Non-Current Assets over 5 years: stood at $35211.0 in 2022, then decreased by 18.6% to $28663.0 in 2023, then grew by 23.01% to $35257.0 in 2024, then slumped by 77.58% to $7905.0 in 2025, then soared by 37.03% to $10832.0 in 2026.
- Business Quant data shows BJDX's Other Non-Current Assets at $10832.0 in Q1 2026, $7905.0 in Q4 2025, and $8727.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 10,832.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,832.00 |
| Dec 31, 2025 | 7,905.00 |
| Sep 30, 2025 | 8,727.00 |
| Jun 30, 2025 | 22,164.00 |
| Mar 31, 2025 | 34,435.00 |
| Dec 31, 2024 | 35,257.00 |
| Sep 30, 2024 | 23,598.00 |
| Jun 30, 2024 | 24,407.00 |
| Mar 31, 2024 | 25,215.00 |
| Dec 31, 2023 | 28,663.00 |
| Sep 30, 2023 | 29,907.00 |
| Jun 30, 2023 | 31,675.00 |
| Mar 31, 2023 | 33,443.00 |
| Dec 31, 2022 | 35,211.00 |
| Sep 30, 2022 | 33,479.00 |
| Jun 30, 2022 | 35,075.00 |
| Mar 31, 2022 | 20,231.00 |
| Dec 31, 2021 | 21,019.00 |